Retracted: Yu, L., Li, H., Liu, W., Zhang, L., Tian, Q., Li, H., & Li, M. (2021). miR‐485‐3p serves as a biomarker and therapeutic target of Alzheimer's disease via regulating neuronal cell viability and neuroinflammation by targeting AKT3. Molecular Genetics & Genomic Medicine , 9 (1), e1548. https://onlinelibrary.wiley.com/doi/10.1002/mgg3.1548

Author unknown

DOI: 10.1002/mgg3.1813
Published: 2021-12-06
Container: Molecular Genetics & Genomic Medicine
Publisher: Wiley
Open access: unknown

Credibility signals

serious concern Score 23/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
serious concernRetraction Watch retraction: 1 retraction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/mgg3.1813,
  title = {Retracted: Yu, L., Li, H., Liu, W., Zhang, L., Tian, Q., Li, H., \&amp; Li, M. (2021). miR‐485‐3p serves as a biomarker and therapeutic target of Alzheimer's disease via regulating neuronal cell viability and neuroinflammation by targeting AKT3.
                    <i>Molecular Genetics \&amp; Genomic Medicine</i>
                    ,
                    <i>9</i>
                    (1), e1548. https://onlinelibrary.wiley.com/doi/10.1002/mgg3.1548},
  year = {2021},
  journal = {Molecular Genetics \&amp; Genomic Medicine},
  doi = {10.1002/mgg3.1813},
  url = {https://doi.org/10.1002/mgg3.1813}
}

RIS

TY  - JOUR
TI  - Retracted: Yu, L., Li, H., Liu, W., Zhang, L., Tian, Q., Li, H., &amp; Li, M. (2021). miR‐485‐3p serves as a biomarker and therapeutic target of Alzheimer's disease via regulating neuronal cell viability and neuroinflammation by targeting AKT3.
                    <i>Molecular Genetics &amp; Genomic Medicine</i>
                    ,
                    <i>9</i>
                    (1), e1548. https://onlinelibrary.wiley.com/doi/10.1002/mgg3.1548
PY  - 2021
JO  - Molecular Genetics &amp; Genomic Medicine
DO  - 10.1002/mgg3.1813
UR  - https://doi.org/10.1002/mgg3.1813
ER  -

APA

Retracted: Yu, L., Li, H., Liu, W., Zhang, L., Tian, Q., Li, H., & Li, M. (2021). miR‐485‐3p serves as a biomarker and therapeutic target of Alzheimer's disease via regulating neuronal cell viability and neuroinflammation by targeting AKT3. Molecular Genetics & Genomic Medicine , 9 (1), e1548. https://onlinelibrary.wiley.com/doi/10.1002/mgg3.1548. (2021). Molecular Genetics & Genomic Medicine. https://doi.org/10.1002/mgg3.1813

Source records

crossref · retrieved 2026-09-27T11:44:45.506Z